Independent review will judge success of SMC system Related items from OnMedica Cancer drug access in England is a ‘debacle’ Cancer Drugs Fund axes 25 treatments from list NHS cash pressures causing bad rationing decisions NICE’s cost-effectiveness system is harming patients, claim experts The medicine price debate |
No comments:
Post a Comment